This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Quantitative Imaging Network | |
|---|---|
| Name | Quantitative Imaging Network |
| Formation | 2008 |
| Headquartered in | Bethesda, Maryland |
| Parent organization | National Institutes of Health National Cancer Institute |
| Type | Research consortium |
| Purpose | Development and validation of quantitative imaging methods for oncology |
Quantitative Imaging Network
The Quantitative Imaging Network is a cancer imaging consortium established to develop, optimize, and validate quantitative imaging methods to improve clinical decision-making in oncology. The Network coordinates collaborations among academic centers, federal agencies, private institutes, and international partners to standardize imaging biomarkers, harmonize protocols, and translate software into multicenter trials. Member teams engage with regulatory bodies, clinical cooperative groups, and industry stakeholders to accelerate adoption of validated imaging tools.
The Network assembles multidisciplinary teams from institutions such as Johns Hopkins University, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, University of California, Los Angeles, University of Pennsylvania, Duke University, Stanford University, University of Texas MD Anderson Cancer Center, University of Michigan, Columbia University, Yale University, University of Washington, University of California, San Francisco, University of Chicago, University of Pittsburgh, Oxford University, Cambridge University, Karolinska Institutet, Imperial College London, Institut Gustave Roussy, Karlsruhe Institute of Technology, Max Planck Society, ETH Zurich, University of Toronto, University of British Columbia, McGill University, Scripps Research Institute, Fred Hutchinson Cancer Research Center, Weill Cornell Medicine, Vanderbilt University Medical Center, Boston University, Penn State University, Northwestern University, Ohio State University, University of Florida, Emory University, Rice University, Rochester Institute of Technology, Rensselaer Polytechnic Institute, Cleveland Clinic, Leiden University Medical Center, Seoul National University, Peking University, Tsinghua University, National University of Singapore to integrate expertise in radiology, oncology, physics, engineering, and bioinformatics. Collaborations extend to regulatory and standards organizations including Food and Drug Administration, European Medicines Agency, International Atomic Energy Agency, International Organization for Standardization, Society of Nuclear Medicine and Molecular Imaging, Radiological Society of North America, American College of Radiology, American Society of Clinical Oncology, and European Society for Medical Oncology.
The initiative originated within programs of the National Cancer Institute and built on precedents such as the Early Detection Research Network, Cancer Imaging Archive, and cooperative groups like EORTC and Children's Oncology Group. Launch activities involved workshops with stakeholders from World Health Organization, Centers for Disease Control and Prevention, Defense Advanced Research Projects Agency, and private consortia including Cancer Research UK and the Wellcome Trust. Early milestones included consensus statements at meetings of the American Association for Cancer Research, methodology papers presented at conferences organized by the International Society for Magnetic Resonance in Medicine, IEEE Medical Imaging Conference, and the SPIE Medical Imaging Symposium, and pilot multicenter trials coordinated with National Surgical Adjuvant Breast and Bowel Project partners.
Governance includes steering committees, working groups, and site principal investigators drawn from academic centers such as Harvard Medical School, University of Oxford, University College London, University of Melbourne, Monash University, Duke-NUS Medical School, Karolinska University Hospital, Mayo Clinic Scottsdale, NIH Clinical Center, Cleveland Clinic Foundation, Johns Hopkins Hospital, Toronto General Hospital, Mount Sinai Hospital (New York), Brigham and Women's Hospital, Hospital of the University of Pennsylvania, Children's Hospital of Philadelphia, Massachusetts General Hospital Cancer Center, Vanderbilt-Ingram Cancer Center, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, Fred Hutch, City of Hope, Moffitt Cancer Center, St. Jude Children's Research Hospital, Dana-Farber Cancer Institute, Addenbrooke's Hospital, Guy's Hospital, Royal Marsden Hospital, Hôpital Européen Georges-Pompidou, and Hospital Clínic de Barcelona. Liaison roles connect the Network to cooperative groups like Alliance for Clinical Trials in Oncology and SWOG.
Research targets quantitative biomarkers in modalities including Magnetic Resonance Imaging, Positron Emission Tomography, Computed Tomography, Ultrasound, Digital Pathology, Optical Imaging, Single Photon Emission Computed Tomography, Cone Beam CT, Dual-energy CT, Diffusion-weighted MRI, and Dynamic Contrast-Enhanced MRI. Projects encompass tumor response assessment, radiomics studies tied to The Cancer Genome Atlas, imaging genomics linking to Genome-wide association study findings, and radiotherapy planning synergies with National Comprehensive Cancer Network guidelines. Trials have been aligned with cooperative oncology trials from Children's Oncology Group, Gynecologic Oncology Group, and multicenter efforts coordinated with European Organisation for Research and Treatment of Cancer.
Methodological work emphasizes standardization of acquisition and analysis protocols conforming to standards from DICOM, NEMA, ISO/TC 210, and consensus recommendations by organizations such as American College of Radiology and Radiological Society of North America. Validation studies reference phantom standards developed in collaboration with National Institute of Standards and Technology and harmonization activities with International Electrotechnical Commission. Metric definitions draw on frameworks from Quantitative Imaging Biomarkers Alliance and reporting templates promoted by STARD and CONSORT-aligned extensions for imaging biomarkers.
Data sharing leverages platforms such as The Cancer Imaging Archive, cloud services including those from Amazon Web Services and Google Cloud Platform, and federated models endorsed by Global Alliance for Genomics and Health. Software toolchains integrate open-source packages and frameworks like ITK, VTK, 3D Slicer, OsiriX, pydicom, SimpleITK, scikit-image, TensorFlow, PyTorch, R Project, Bioconductor, MATLAB, C++ Boost Libraries, GitHub, Docker containers, and workflow managers such as Nextflow and Snakemake. Data governance and de-identification practices reference standards from the Health Insurance Portability and Accountability Act and are informed by ethics review boards at institutions including Institutional Review Board panels at participating centers.
The Network's outputs inform guidance from regulatory authorities including the Food and Drug Administration and influence imaging endpoints in protocols by cooperative groups like SWOG, Alliance for Clinical Trials in Oncology, and NRG Oncology. Collaborations extend to industry partners such as Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Varian Medical Systems, Elekta, Roche Diagnostics, and biotech firms involved in radiotracers. Translation pathways include multicenter validation studies published in journals like Journal of Clinical Oncology, Radiology, European Radiology, Nature Medicine, and Lancet Oncology and uptake in clinical guidelines by organizations such as National Comprehensive Cancer Network and European Society for Radiology. Educational outreach has occurred at meetings of Radiological Society of North America, American Society of Clinical Oncology, Society of Nuclear Medicine and Molecular Imaging, European Society for Medical Oncology, and American Association for Cancer Research to accelerate adoption across academic hospitals and cancer centers.
Category:Cancer research organizations